IMS offers a complete, clinically-rich view of the global oncology market in seven key countries…the U.S., Japan, Germany, UK, France, Italy and Spain. This information, combined with our anonymized patient level data and sales and prescription insights, provides clients with one of the most comprehensive views of the oncology market available today.

With our global network of oncology experts and evidential databases developed over 50 years, IMS has the clinical depth, commercial breadth and global reach clients need to maximize the value of their products across the entire oncology lifecycle.

IMS Oncology has world class leaders in:

• Competitive intelligence
• Market sizing and forecasting
• Brand positioning
• Pricing
• Market access
• Health economics and outcomes research

For more information on how IMS can transform its clinical and market insights into successful strategies for your business, visit us at: http://www.imshealth.com/oncology